If you are a subscriber, please Log In.

Cabot Profit Booster

Latest Issue

Cabot Profit Booster 125

May 27, 2020

This biopharmaceutical firm acquires, rebrands and reprices drugs for sale in the U.S., with many that treat inflammatory conditions, including a few that take aim at rare diseases.

Updates

May 14, 2020

Tomorrow is the expiration of May options, and it's been a spectacular month for our covered call strategy.
View Update

View Update Archive